GCM
CANO

Glenview Capital Management’s Cano Health, Inc. CANO Stock Holding History

Glenview Capital Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$254K – 55
2023
Q3 		$254K Sell
10,000
-7,001
-41% -$576K 0.01% 50
2023
Q2 		$2.36M Buy
17,001
+7,500
+79% +$962K 0.05% 43
2023
Q1 		$865K Buy
+9,501
New +$1.29M 0.02% 52

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Glenview Capital Management's CANO Position: Q4 2023 in Review

Glenview Capital Management sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 10,000 shares — an estimated $254K sold.

Glenview Capital Management first reported a position in CANO in Q1 2023 and held it in 3 quarters. The position peaked at $2.36M in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Glenview Capital Management reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Glenview Capital Management sold 10,000 Cano Health, Inc. shares in Q4 2023, an estimated $254K.
  • Glenview Capital Management first reported a position in Cano Health, Inc. in Q1 2023 and held it in 3 quarters.
  • Glenview Capital Management's Cano Health, Inc. position peaked at $2.36M in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Glenview Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.